GENOMIC ANALYSIS OF THE F-SUBTYPES OF HUMAN-COMPLEMENT FACTOR-B

被引:12
作者
JAHN, I
MEJIA, JE
THOMAS, M
DARKE, C
SCHRODER, H
GESERICK, G
HAUPTMANN, G
机构
[1] NATL BLOOD TRANSFUS SERV, REG TISSUE TYPING LAB, CARDIFF, S GLAM, WALES
[2] HUMBOLDT UNIV BERLIN, INST GERICHTLICHE MED, BERLIN, GERMANY
来源
EUROPEAN JOURNAL OF IMMUNOGENETICS | 1994年 / 21卷 / 06期
关键词
D O I
10.1111/j.1744-313X.1994.tb00214.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Factor B of human complement is encoded within the Major Histocompatibility Complex (MHC) and is polymorphic, with up to 30 alleles defined by electrophoretic mobility. One of the most common alleles, BF*F, is subdivided into the FA and FB subtypes, which differ at the gene level by non-synonymous base substitutions in the seventh codon. We have found at this position a new restriction site polymorphism, as a Bsl I site absent from the FB allele. Using this restriction polymorphism, we have developed a method for BF F subtype determination, based on amplification by polymerase chain reaction of the 5' end of the BF gene, and digestion with Bsl I. This new method has been applied to a panel of 29 selected BF F individuals. A single strand DNA conformation analysis of the same region of the gene allowed us to confirm the above DNA-based BF F subtyping. During this study, two BF*F1 alleles showed discrepancies between protein and DNA typing, which were confirmed by our sequencing data. These were identical, in the 5' region, to BF*S and BF*FB genes, respectively. In a comparison with two protein subtyping methods, identical results were found for only one third of the selected samples. The conflicting results may arise, in part, from previously undescribed molecular heterogeneity within BF F subtypes, or from the presence of a null allele. Our new method allows FF*F subtyping to be used with confidence in the definition of disease-associated MHC haplotypes.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 28 条
[1]  
ABBAL M, 1987, Complement, V4, P124
[2]   2 SUBTYPES OF BFF BY ISOELECTROFOCUSING - DIFFERENTIAL LINKAGE TO OTHER HLA MARKERS [J].
ABBAL, M ;
THOMSEN, M ;
CAMBONTHOMSEN, A ;
ARCHAMBEAU, J ;
CALOT, M ;
FATHALLAH, D .
HUMAN GENETICS, 1985, 69 (02) :181-183
[3]   BF DNA REFERENCE TYPING [J].
ABBAL, M ;
DAVRINCHE, C .
COMPLEMENT AND INFLAMMATION, 1990, 7 (4-6) :190-192
[4]   HAPLOTYPE ANALYSIS OF LINKAGE GROUP HLA-A=HLA-B=BF AND ITS BEARING ON INTERPRETATION OF LINKAGE DISEQUILIBRIUM [J].
BENDER, K ;
MAYEROVA, A ;
FRANK, R ;
HILLER, C ;
WIENKER, T .
HUMAN GENETICS, 1977, 36 (02) :191-196
[5]  
BENTLEY DR, 1986, BIOCHEM SOC SYMP, P7
[6]  
BUDOWLE B, 1982, CANCER, V50, P2369, DOI 10.1002/1097-0142(19821201)50:11<2369::AID-CNCR2820501123>3.0.CO
[7]  
2-S
[8]  
DAVRINCHE C, 1990, IMMUNOGENETICS, V32, P309
[9]  
DELSAL G, 1989, BIOTECHNIQUES, V7, P514
[10]   HLA-LINKED COMPLEMENT POLYMORPHISMS (C2, BF) IN PSORIASIS [J].
DEWALD, G ;
LANGE, CE ;
SCHMEEL, E ;
KREYSEL, HW .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1983, 275 (05) :301-304